ARTICLE | Clinical News
Alpha 1 Biomedicals regulatory update
January 3, 1994 8:00 AM UTC
ALBM (Bethesda, Md.) acquired from George Washington University the rights to U.S. Patent No. 5,273,963, which covers methods for treating small cell and non-small cell lung cancers using thymosin. Th...